Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utilization in the tumor microenvironment
Elizabeth G. Hunt, Katie E. Hurst, Brian Riesenberg, et al.
Cell Metabolism (2024) Vol. 36, Iss. 5, pp. 969-983.e10
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Metformin-based nanomedicines for reprogramming tumor immune microenvironment
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 28
Targeting lipid metabolism in regulatory T cells for enhancing cancer immunotherapy
Yang Liu, Xingyue Wang, Shu‐Rong Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189259-189259
Open Access | Times Cited: 2
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Kun Huang, Ying Han, Yihong Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8+ T cell fitness in solid tumours
Samantha Pretto, Qian Yu, Pierre Bourdely, et al.
Nature Metabolism (2025)
Open Access | Times Cited: 1
Regulation of CD8+ T cells by lipid metabolism in cancer progression
Yong Tang, Ziqing Chen, Qianying Zuo, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 11, pp. 1215-1230
Open Access | Times Cited: 5
Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy
Hongyan Zhang, Yujie Li, Jingyi Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4717-4737
Open Access | Times Cited: 4
Targeting P4HA1 promotes CD8+ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity
Shijun Ma, L.S. Ong, Zemin Jiang, et al.
Cancer Cell (2024)
Closed Access | Times Cited: 4
Mitochondrial fatty acid oxidation regulates monocytic type I interferon signaling via histone acetylation
Jing Wu, Komudi Singh, Vivian Shing, et al.
Science Advances (2025) Vol. 11, Iss. 4
Open Access
Modulating lipid metabolism improves tumor immunotherapy
Yu Ping, Qixuan Fan, Yi Zhang
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010824-e010824
Open Access
Unexpected links between cancer and telomere state
Alessio Lanna
Seminars in Cancer Biology (2025) Vol. 110, pp. 46-55
Closed Access
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications
Xiaowen Xie, Weici Liu, Zhiyuan Yuan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
The tumor microenvironment is an ecosystem sustained by metabolic interactions
Emily Kay, Sara Zanivan
Cell Reports (2025) Vol. 44, Iss. 3, pp. 115432-115432
Open Access
Metabolic reprogram and T cell differentiation in inflammation: current evidence and future perspectives
Yuxin Shi, Hao Zhang, Changhong Miao
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Metabolic Reprogramming of Tumor Microenviroment by Engineered Bacteria
Heng Wang, Fang Xu, Chao Wang
Seminars in Cancer Biology (2025)
Closed Access
Stimulation of regulatory dendritic cells suppresses cytotoxic T cell function and alleviates DEN-induced liver injury, fibrosis and hepatocellular carcinoma
Jun‐Jie Wang, Ping Gong, Qingqing Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Targeting metabolic circuitry to supercharge CD8+ T cell antitumor responses
Qiang Cai, Yihao Tian, Quazi T.H. Shubhra
Cell Metabolism (2024) Vol. 36, Iss. 5, pp. 884-886
Closed Access | Times Cited: 3
Fatty acid metabolism constrains Th9 cell differentiation and antitumor immunity via the modulation of retinoic acid receptor signaling
Takahiro Nakajima, Toshio Kanno, Youki Ueda, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 11, pp. 1266-1281
Open Access | Times Cited: 2
Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy
Zhouchi Yao, Yayun Zeng, Cheng Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Advancements in Cancer Research: 3D Models, Single‐Cell, and Live‐Cell Techniques for Better Insights
Federica Carnevali, Stefania Forciniti, Valentina Onesto, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 12
Open Access | Times Cited: 2
Targeting lipid metabolism via nanomedicine: a prospective strategy for cancer therapy
Xing Huang, Shengzhong Hou, Yinggang Li, et al.
Biomaterials (2024) Vol. 317, pp. 123022-123022
Closed Access | Times Cited: 2
T-Cell Metabolic Reprogramming in Atherosclerosis
Shuye Chang, Zhaohui Wang, Tianhui An
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1844-1844
Open Access | Times Cited: 1
Metabolomic Profiling Reveals Potential of Fatty Acids as Regulators of Stem-like Exhausted CD8 T Cells During Chronic Viral Infection
Katelynn R. Kazane, Lara Labarta-Bajo, Dina Zangwill, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Optimizing CD8+ T cell-based immunotherapy via metabolic interventions: a comprehensive review of intrinsic and extrinsic modulators
Zihao Zhou, Jiarong Zheng, Ye Lu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity
Mario Cioce, Mariamena Arbitrio, Nicoletta Polerà, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Mengdi Ma, Yongliang Zhang, Kanyi Pu, et al.
Chemical Society Reviews (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top